Adobe To Rally Over 14%? Here Are 10 Other Analyst Forecasts For Tuesday
Portfolio Pulse from Lisa Levin
Several analyst forecasts were released on Tuesday, with notable changes in price targets for various companies. CareTrust REIT, Adobe, Sight Sciences, IAMGOLD Corporation, RTX Corporation, Cintas Corporation, AngloGold Ashanti Limited, Enphase Energy, Oracle Corporation, FedEx Corporation, and IDEAYA Biosciences were all mentioned. The changes in price targets were accompanied by upgrades or downgrades in stock ratings.
September 12, 2023 | 12:49 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Truist Securities downgraded Enphase Energy from Buy to Hold and cut its price target from $210 to $135.
The downgrade and significant decrease in price target by Truist Securities indicates a negative outlook for Enphase Energy, which could lead to a short-term decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Barclays downgraded RTX Corporation from Overweight to Equal-Weight and slashed its price target from $100 to $75.
The downgrade and significant decrease in price target by Barclays indicates a negative outlook for RTX Corporation, which could lead to a short-term decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Piper Sandler downgraded Sight Sciences from Overweight to Neutral and slashed its price target from $15 to $5.5.
The downgrade and significant decrease in price target by Piper Sandler indicates a negative outlook for Sight Sciences, which could lead to a short-term decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
UBS maintained a Buy rating for Oracle Corporation but cut its price target from $140 to $135.
The maintained Buy rating by UBS suggests a positive outlook for Oracle Corporation, but the decrease in price target could indicate some potential risks, leading to a neutral short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
BMO Capital maintained an Outperform rating for Adobe and raised its price target from $600 to $640.
The maintained Outperform rating and increased price target by BMO Capital suggests a positive outlook for Adobe, potentially leading to a short-term increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
BMO Capital upgraded AngloGold Ashanti Limited from Market Perform to Outperform and raised its price target from $19 to $22.
The upgrade and increased price target by BMO Capital indicates a positive outlook for AngloGold Ashanti Limited, which could lead to a short-term increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
B of A Securities upgraded Cintas Corporation from Neutral to Buy and increased its price target from $523 to $580.
The upgrade and increased price target by B of A Securities indicates a positive outlook for Cintas Corporation, which could lead to a short-term increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
RBC Capital upgraded CareTrust REIT from Sector Perform to Outperform and raised its price target from $19 to $23.
The upgrade and increased price target by RBC Capital indicates a positive outlook for CareTrust REIT, which could lead to a short-term increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Wells Fargo maintained an Equal-Weight rating for FedEx Corporation and raised its price target from $240 to $270.
The maintained Equal-Weight rating and increased price target by Wells Fargo suggests a positive outlook for FedEx Corporation, potentially leading to a short-term increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
RBC Capital upgraded IAMGOLD Corporation from Underperform to Sector Perform and raised its price target from $1.75 to $2.75.
The upgrade and increased price target by RBC Capital indicates a positive outlook for IAMGOLD Corporation, which could lead to a short-term increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Goldman Sachs maintained a Buy rating for IDEAYA Biosciences and boosted its price target from $31 to $37.
The maintained Buy rating and increased price target by Goldman Sachs indicates a positive outlook for IDEAYA Biosciences, which could lead to a short-term increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100